Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.
CODECHECK
Show more
Diagnostic kits comprised of medical diagnostic reagents, assays, and nasopharyngeal and pharyngeal swabs for medical use for the testing of bodily fluids for use in disease detection, namely, a polymerase chain reaction (PCR) testing kit for the detection of SARS-COV-2; medical diagnostic kits composed primarily of diagnostic preparations for medical diagnostic purposes that prepares, modifies, and manipulates samples and for making, separating, isolating, purifying, reproducing and analyzing biopolymers in the nature of nucleic acids, proteins, macromolecules and biologically active substances being nucleic acids from biological or biochemical sample material
Class 5 – Pharmaceuticals & supplements
Status timeline
- 3 Jan 2022Application filedNew Application Entered
- 6 Sep 2022Assigned to an examining attorneyAssigned To Examiner
- 16 Sep 2022Approved for publicationApproved For Pub - Principal Register
- 25 Oct 2022Published for oppositionPublished For Opposition
- 10 Jan 2023Registered on the Principal RegisterRegistered-Principal Register
All 13 events
| 2023-01-10 | Registered-Principal Register |
| 2023-01-10 | Notice Of Registration Confirmation Emailed |
| 2022-10-25 | Published For Opposition |
| 2022-10-25 | Official Gazette Publication Confirmation E-Mailed |
| 2022-10-05 | Notification Of Notice Of Publication E-Mailed |
| 2022-09-16 | Approved For Pub - Principal Register |
| 2022-09-14 | Examiners Amendment -Written |
| 2022-09-14 | Examiners Amendment E-Mailed |
| 2022-09-14 | Notification Of Examiners Amendment E-Mailed |
| 2022-09-14 | Examiner's Amendment Entered |
| 2022-09-06 | Assigned To Examiner |
| 2022-01-05 | New Application Office Supplied Data Entered |
| 2022-01-03 | New Application Entered |
Goods & services by class
Class 5 Pharmaceuticals & supplements
Diagnostic kits comprised of medical diagnostic reagents, assays, and nasopharyngeal and pharyngeal swabs for medical use for the testing of bodily fluids for use in disease detection, namely, a polymerase chain reaction (PCR) testing kit for the detection of SARS-COV-2; medical diagnostic kits composed primarily of diagnostic preparations for medical diagnostic purposes that prepares, modifies, and manipulates samples and for making, separating, isolating, purifying, reproducing and analyzing biopolymers in the nature of nucleic acids, proteins, macromolecules and biologically active substances being nucleic acids from biological or biochemical sample material
First use anywhere 30 Jul 2020 · First use in commerce 30 Jul 2020
Owner details
See the official record for contact details. View official record →
Source & freshness
Source: the official United States trademark register. This record was last updated on 10 Jan 2023; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.